As an Investor Engagement Officer at the Access to Medicine Foundation, Twinelle Baidoo manages
relationships with institutional investors. She engages portfolio managers, healthcare analysts, and
ESG professionals across the investor community, leveraging the Foundation’s research, to enhance
their understanding of how pharmaceutical companies navigate risks and opportunities related to
access to medicine and antimicrobial resistance (AMR).
Twinelle began her career as a clinician in the National Health Service (NHS), specialising in acute medicine and geriatrics. During her time as a clinician, she led a significant COVID-19 initiative focused on improving clinical staff-patient communication and improving health outcomes of marginalised populations.
Twinelle's commitment to health equity is evidenced by her Master of Public Health from Imperial College London, where she conducted a systematic review on the impact of user fees on access to general practice in the European Union, currently undergoing publication.